Cite
HARVARD Citation
Matulonis, U. et al. (2015). Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials. Cancer. 121 (11), pp. 1737-1746. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Matulonis, U. et al. (2015). Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials. Cancer. 121 (11), pp. 1737-1746. [Online].